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Background: Although significant in-hospital mortality for non-ST-elevation myocardial infarction (NSTEMI) patients complicated by cardiogenic 
shock (CS) is well known, the long-term prognosis among CS patients who survive the index hospitalization has not been well characterized.
Methods: Patients with NSTEMI ≥ 65 years from the CRUSADE registry treated at 448 US hospitals from 2003-2006 were linked to Medicare 
longitudinal claims data. We used Cox proportional hazards modeling to compare all-cause mortality between patients with and without CS (on 
presentation and/or development in hospital).
Results: Among 42,657 NSTEMI patients, 4.7% had CS. Rates of in-hospital mortality were 39.1% and 4.5% for patients with and without CS 
(p<0.001). Of the 40,037 index hospital survivors (median age 77 years; median follow-up 1056 days), 1218 (3.0%) patients had CS. Use of in-
hospital revascularization was higher for patients with CS (44.5% vs. 41.4%, p=0.02). Mortality curves diverge early after discharge with higher 
adjusted 6-month mortality in patients with CS (HR 1.48, 95%CI 1.31 to 1.68) (figure). Conditional on 6-month survival, adjusted long-term mortality 
is similar between the groups (HR 1.00, 95%CI 0.89 to 1.11).
Conclusions: While acute mortality risk for elderly NSTEMI patients with cardiogenic shock remains high, by 6 months, mortality rates declined to 
rates similar to non-shock patients. Thus, aggressive early intervention in elderly cardiogenic shock patients may be warranted.
